Skip to main content
SpringerLink
Log in

The Policies of Tumor Biobankers: Main Strategies and an Example of the Policies Adopted by the Nice Hospital Biobank, France

  • Chapter
  • First Online:
Public Regulation of Tumor Banks

  • 142 Accesses

Abstract

Biobanks are evolving, as is shown by the emergence of what are known as “Next Generation Tumor Biobanks” (NGTB). In addition, some research activities are being dissociated from healthcare (diagnostic, prognostic, targeted therapy, immunotherapy) and from the development of genomic medicine. Many biobanks are taking on new roles, becoming centers of expertise in a wide variety of fields (clinical, pathology, genomics, bio-statistics, bio-informatics, and even mathematics), as well as repositories for the collection and storage of samples.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Clément, B., Hofman, P., Desille, M., & Dagher, G. (2017). Réalités industrielles. La normalisation des techniques d’ingénierie en recherche biomédicale: l’exemple des centres de ressources biologiques. Annales des Mines, 2, 24–28.

    Google Scholar 

  • Clément, B., Yuille, M., Zaltoukal, K., Wichmann, H. E., Anton, G., Parodi, B., et al. (2014). EU-US expert group on cost recovery in biobanks. Public biobanks: Calculation and recovery of costs. Science Translational Medicine, 6(261), 261fs45.

    Article  Google Scholar 

  • Cooreman, A., Bravo, E., van Gool, A. J., Puchois, P., Roehrl, H. A., & Hofman, P. (2017). Traceability and transparency should be mandatory for all human biospecimens. Applied Clinical Trials, 2, 1–7.

    Google Scholar 

  • Doucet, M., Becker, K. F., Björkman, J., Bonnet, J., Clément, B., Daidone, M. G., et al. (2016). Quality matters: 2016 annual conference of the National Infrastructures for biobanking. Biopreservation and Biobanking, 15, 270–276.

    Article  Google Scholar 

  • Freedman, L. P., Cockburn, I. M., & Simcoe, T. S. (2015). The economics of reproducibility in preclinical research. PLoS Biology, 13(6), e1002165.

    Article  Google Scholar 

  • Gormally, E., Hardy, I., Caboux, E., Di Donato, J. H., Hainaut, P., & Hofman, P. (2017). Training the next generation of biobankers: A two-years Master’s course in the management of biobanks. Biopreservation and Biobanking, 15(5), 438–450.

    Article  Google Scholar 

  • Henderson, M. K., Goldring, K., & Simeon-Dubach, D. (2017). Achieving and maintaining sustainability in biobanking through business planning, marketing, and access. Biopreservation and Biobanking, 15(1), 1–2.

    Article  Google Scholar 

  • Hofman, V., Ilie, M., Long, E., Washetine, K., Chabannon, C., Figarella-Branger, D., et al. (2013). Measuring the contribution of tumor biobanks to research in oncology: Surrogate indicators and bibliographic output. Biopreservation and Biobanking, 11(4), 235–244.

    Article  Google Scholar 

  • Hofman, P. (2006). The CHU-CRLCC-UNSA tumour/tissue bank of the nice area. Medical Science (Paris), 22(1), 21–25.

    Article  Google Scholar 

  • Hofman, V., Bonnetaud, C., Gaziello, M. C., Ilie, M., Lassalle, S., Butori, C., et al. (2010). The nice CHU biobank experience to collect patients’ informed consent for research context (2004-2009). Annales de Pathologie, 30(5), 337–343.

    Article  Google Scholar 

  • Hofman, P., Bréchot, C., Zatloukal, K., Dagher, G., & Clément, B. (2014). Public-private relationships in biobanking: A still underestimated key component of open innovation. Virchows Archiv, 464(1), 3–9.

    Article  Google Scholar 

  • http://www.rfidjournal.com/article/view8303. French biobank secure specimens.

  • Ilie, M., Szafer-Glusman, E., Hofman, V., Long-Mira, E., Suttmann, R., Darbonne, W., et al. (2017). Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients. Oncotarget, 8, 26112–26121.

    Google Scholar 

  • Ilie, M., Nunes, M., Blot, L., Hofman, V., Long-Mira, E., Butori, C., et al. (2015). Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps. Cancer Medicine, 4(2), 201–211.

    Article  Google Scholar 

  • Long, E., Hofman, V., Ilie, M., Washetine, K., Lespinet, V., Bonnetaud, C., et al. (2013). Accreditation of the activity of molecular pathology according to ISO 15189: Key steps to follow and the main potential pitfalls. Annales de Pathologie, 33(1), 12–23.

    Article  Google Scholar 

  • Long-Mira, E., Washetine, K., & Hofman, P. (2016). Sense and nonsense in the process of accreditation of a pathology laboratory. Virchows Archiv, 468(1), 43–49.

    Article  Google Scholar 

  • Lassalle, S., Hofman, V., Ilie, M., Butori, C., Bonnetaud, C., Gaziello, M. C., et al. (2011). Setting up a prospective thyroid biobank for translational research: Practical approach of a single institution (2004-2009, Pasteur hospital, nice, France). Biopreservation and Biobanking, 9(1), 9–19.

    Article  Google Scholar 

  • Mabile, L., Dalgleish, R., Thorisson, G. A., Deschênes, M., Hewitt, R., Carpenter, J., et al. (2013). BRIF working group: Quantifying the use of bioresources for promoting their sharing in scientific research. Gigascience., 2(1), 7.

    Article  Google Scholar 

  • Macheiner, T., Huppertz, B., Bayer, M., & Sargsyan, K. (2017). Challenges and driving forces for business plans in biobanking. Biopreservation and Biobanking, 15(2), 121–125.

    Article  Google Scholar 

  • Rakha, E., Pajares, M. J., Ilie, M., Pio, R., Echeveste, J., Hughes, E., et al. (2015). Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators. European Journal of Cancer, 51(14), 1897–1903.

    Article  Google Scholar 

  • Washetine, K., Ilié, I., Hofman, P., Butori, C., Long, E., Lassalle, S., et al. (2017a). Les biobanques : quels enjeux en 2017 ? Revue Francophone Des Laboratoires, 448, 25–28.

    Article  Google Scholar 

  • Washetine, K., Hofman, V., Lassalle, S., Long, E., Ilié, M., Butori, C., et al. (2017b). L’accréditation des laboratoires d’ACP : pourquoi est-ce incontournable? Revue Francophone Des Laboratoires, 448, 31–37.

    Article  Google Scholar 

  • Yuille, M., van Ommen, G. J., Bréchot, C., Cambon-Thomsen, A., Dagher, G., Landegren, U., et al. (2008). Biobanking for Europe. Briefings in Bioinformatics, 9(1), 14–24.

    Article  Google Scholar 

  • Yuille, M. M., Feller, P. I., Georghiou, L., Laredo, P., & Welch, E. W. (2017). Financial sustainability of biobanks: From theory to practice. Biopreservation and Biobanking, 15(2), 85–92.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Clinical and Experimental Pathology, Nice Hospital Biobank (BB-0033-00025), University Hospital Federation OncoAge, Pasteur Hospital, Nice, France

    Paul Hofman

Authors
  1. Paul Hofman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Hofman .

Editor information

Editors and Affiliations

  1. Toulouse 1 Capitole University , Toulouse, France

    Xavier Bioy

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hofman, P. (2018). The Policies of Tumor Biobankers: Main Strategies and an Example of the Policies Adopted by the Nice Hospital Biobank, France. In: Bioy, X. (eds) Public Regulation of Tumor Banks. Springer, Cham. https://doi.org/10.1007/978-3-319-90563-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90563-1_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90562-4

  • Online ISBN: 978-3-319-90563-1

  • eBook Packages: Law and CriminologyLaw and Criminology (R0)

Publish with us

Policies and ethics

Search

Navigation